Astellas Pharma, Inc.(ALPMY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALPMY Astellas Pharma, Inc.

盘后交易 06-17 15:58:00 EDT 延时

{"stockData":{"symbol":"ALPMY","market":"US","secType":"STK","nameCN":"Astellas Pharma, Inc.","latestPrice":13.29,"timestamp":1781726280000,"preClose":13.37,"halted":0,"volume":327014,"delay":15,"changeRate":-0.005983545250560963,"floatShares":1745183156,"shares":1790310070,"eps":0.074352,"marketStatus":"盘后交易","change":-0.08,"latestTime":"06-17 15:58:00 EDT 延时","open":13.37,"high":13.51,"low":13.1,"amount":4372689.283924,"amplitude":0.030666,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.074352,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1781740800000},"marketStatusCode":4,"adr":0,"adrRate":1,"exchange":"PINK LIMITED","adjPreClose":13.37,"volumeRatio":1.488695},"requestUrl":"/m/hq/s/ALPMY/tweets","defaultTab":"tweets","newsList":[{"id":"1159770601","title":"安斯泰来制药：FDA根据《处方药使用者费用法案》设定2026年8月17日为关键审批日期","url":"https://stock-news.laohu8.com/highlight/detail?id=1159770601","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159770601?lang=zh_cn&edition=full","pubTime":"2026-04-20 18:48","pubTimestamp":1776682090,"startTime":"0","endTime":"0","summary":"根据《处方药使用者费用法案》框架，美国食品药品监督管理局已为安斯泰来制药的核心新药申请划定重要时间节点——2026年8月17日被正式确立为监管审评的目标行动日期。这一关键时间点的设定，标志着该创新疗法的审评进程进入倒计时阶段，为市场预期提供了明确的时间坐标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","ALPMY","IE00B19Z3581.USD","BK4585","BK4599","LU1066051498.USD","SG9999002224.SGD","LU0058720904.USD","LU0225284248.USD","SG9999001176.SGD","BK4588","LU0289739699.SGD","LU1883839398.USD","LU1894683264.USD","LU0306807586.USD","LU0456855351.SGD","SG9999013999.USD","IE00BBT3K403.USD","IE00BLSP4452.SGD","LU1057294990.SGD","LU1066053197.SGD","LU1023059063.AUD","SGXZ57979304.SGD","LU0321505439.SGD","LU0321505868.SGD","IE00BLSP4239.USD","BK4533","LU0868494617.USD","LU0225771236.USD","BK4534","LU0306806265.USD","SG9999002232.USD","IE00B19Z3B42.SGD","BK4550","IE0002270589.USD","LU0234572021.USD","LU0985481810.HKD","BK4592","LU0170899867.USD","SG9999001176.USD","SG9999011175.SGD","LU1894683348.USD","BK4007","ALPMF","SG9999003800.SGD","BK4568","BK4581","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164144381","title":"安斯泰来：EV-304研究中围术期enfortumab vedotin联合帕博利珠单抗的安全性特征与既往联合用药经验一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1164144381","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164144381?lang=zh_cn&edition=full","pubTime":"2026-02-27 23:05","pubTimestamp":1772204701,"startTime":"0","endTime":"0","summary":"根据EV-304研究数据，安斯泰来制药公司公布的最新结果显示，在围术期使用enfortumab vedotin联合帕博利珠单抗的治疗方案，其安全性特征与先前对该联合疗法的经验保持一致。\n这一发现进一步支持了该联合治疗方案在临床应用中的安全性一致性，为后续治疗策略的制定提供了重要参考依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","BK4533","SG9999003800.SGD","BK4585","BK4007","BK4550","LU0321505868.SGD","LU0456855351.SGD","IE00BBT3K403.USD","IE000M9KFDE8.USD","LU1023059063.AUD","BK4568","BK4534","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1894683264.USD","BK4581","IE0002270589.USD","LU0306806265.USD","LU0985481810.HKD","SG9999002224.SGD","SG9999001176.USD","IE00BLSP4452.SGD","BK4588","LU0234572021.USD","BK4599","LU0225284248.USD","LU1066051498.USD","ALPMY","LU1883839398.USD","SG9999011175.SGD","SGXZ57979304.SGD","LU0868494617.USD","IE00BLSP4239.USD","LU0306807586.USD","LU0058720904.USD","LU0170899867.USD","LU1057294990.SGD","LU0225771236.USD","LU1894683348.USD","SG9999001176.SGD","SG9999013999.USD","SG9999002232.USD","LU0321505439.SGD","LU1066053197.SGD","BK4592","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508412971","title":"美国OTC市场安斯泰莱制药盘中异动 股价大跌5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508412971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508412971?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:46","pubTimestamp":1738593977,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时46分，美国OTC市场安斯泰莱制药股票出现波动，股价快速下挫5.79%。截至发稿，该股报9.12美元/股，成交量7406股，换手率0.00%，振幅5.99%。机构评级方面，在所有14家参与评级的机构中，43%的券商给予买入建议，50%的券商给予持有建议，7%的券商给予卖出建议。美国OTC市场安斯泰莱制药股票所在的制药行业中，整体涨幅为0.08%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224617abc10ae8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224617abc10ae8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALPMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501277310","title":"中国国家药品监督管理局批准备思复（维恩妥尤单抗）联合可瑞达（帕博利珠单抗）用于治疗晚期膀胱癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2501277310","media":"美通社","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501277310?lang=zh_cn&edition=full","pubTime":"2025-01-08 16:05","pubTimestamp":1736323500,"startTime":"0","endTime":"0","summary":"EV-302试验中国主要研究者、北京大学肿瘤医院泌尿肿瘤暨黑色素瘤肉瘤内科主任、中国临床肿瘤学会副理事长兼秘书长郭军教授 \"近日NMPA批准的维恩妥尤单抗联合帕博利珠单抗的治疗组合，是国内获批的首个针对晚期膀胱癌患者的非铂化疗的治疗方案，可用于一线治疗。这次批准维恩妥尤单抗联合帕博利珠单抗的治疗方案，标志着我们再一次为中国患者带来了创新治疗选择。患者随机接受维恩妥尤单抗与帕博利珠单抗联合用药治疗或含铂化疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4591653_ZH91653_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU2089984988.USD","LU2361045086.USD","LU1066051811.HKD","LU0320765489.SGD","BK4007","LU1116320737.USD","IE00BN8TJ469.HKD","LU1291159041.SGD","LU1941712264.USD","SG9999014567.USD","LU0122379950.USD","LU1974910355.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU1983299246.USD","LU2023250843.SGD","LU1941712348.USD","LU0211331839.USD","LU0985320562.USD","IE00BSNM7G36.USD","SG9999014542.SGD","LU0208291251.USD","SG9999014575.USD","MRK","BK4534","LU0070302665.USD","LU1989771016.USD","LU0106261372.USD","IE00BLSP4452.SGD","SGXZ57979304.SGD","LU0965509010.AUD","LU1061106388.HKD","LU1917777945.USD","SG9999002224.SGD","LU0058720904.USD","IE0002141913.USD","LU0965508806.USD","IE0009355771.USD","LU1116320901.HKD","IE00BJJMRZ35.SGD","BK4550","LU1699723380.USD","LU1057294990.SGD","ALPMY","LU2106854487.HKD","LU0234572021.USD","BK4559","LU1037948541.HKD","LU0006306889.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501532952","title":"中国国家药品监督管理局批准威络益（佐妥昔单抗）一线治疗晚期胃或胃食管交界处腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2501532952","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501532952?lang=zh_cn&edition=full","pubTime":"2025-01-06 20:25","pubTimestamp":1736166300,"startTime":"0","endTime":"0","summary":"胃癌是中国与癌症相关死亡的第三大因素，2022年导致超过26万例死亡。近日国家药品监督管理局批准了佐妥昔单抗在中国上市，我们非常激动，它将为我国晚期胃癌患者增添一项宝贵且有效的一线治疗选择。SPOTLIGHT研究探索了佐妥昔单抗联合化疗方案在CLDN18.2阳性、HER2阴性晚期胃和胃食管交界处癌患者一线治疗中的疗效与安全性，在PFS与OS等关键指标上，呈现出统计学上的显著差异。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4589327_ZH89327_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU0950375773.USD","SG9999015986.USD","SG9999002232.USD","BK4515","LU1059921491.USD","IE00BSNM7G36.USD","SG9999015978.USD","SG9999001440.SGD","BK4533","LU1244550221.USD","BK4007","CDC","LU0823417653.USD","LU2237443978.SGD","IE00BGHQF631.EUR","IE00BVYPNW00.USD","LU0234572021.USD","LU1066053197.SGD","SG9999001424.SGD","PFS","LU2506951958.HKD","LU1894683348.USD","LU1235294995.USD","LU0942090050.USD","LU2506952170.USD","LU1571399168.USD","LU2506952097.USD","BK4525","CSCO","LU0234570918.USD","OS","BK4097","LU1066051811.HKD","ALPMY","LU1880398554.USD","BK4527","LU1880398471.USD","LU2237443465.HKD","SG9999015952.SGD","LU2237443895.HKD","LU1066051225.USD","IE00B42XCP33.USD","LU1823568750.SGD","IE00BFXG1179.USD","SG9999015945.SGD","BK4588","IE00BVYPNV92.GBP","LU2286300806.USD","BK4534","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493087988","title":"美国OTC市场安斯泰莱制药盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493087988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493087988?lang=zh_cn&edition=full","pubTime":"2024-12-24 22:46","pubTimestamp":1735051571,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日22时46分，美国OTC市场安斯泰莱制药股票出现异动，股价大幅上涨5.08%。截至发稿，该股报10.13美元/股，成交量9.709万股，换手率0.01%，振幅7.78%。机构评级方面，在所有14家参与评级的机构中，43%的券商给予买入建议，50%的券商给予持有建议，7%的券商给予卖出建议。美国OTC市场安斯泰莱制药股票所在的制药行业中，整体跌幅为0.86%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224224611ab90bd69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224224611ab90bd69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALPMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2487568246","title":"美国OTC市场安斯泰莱制药盘中异动 股价大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487568246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487568246?lang=zh_cn&edition=full","pubTime":"2024-11-29 22:46","pubTimestamp":1732891562,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时46分，美国OTC市场安斯泰莱制药股票出现异动，股价大幅上涨5.25%。截至发稿，该股报10.83美元/股，成交量182股，换手率0.00%，振幅0.00%。美国OTC市场安斯泰莱制药股票所在的制药行业中，整体涨幅为0.41%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129224602a25f7d8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129224602a25f7d8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BFRI","BK4007","ALPMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2485418890","title":"美国OTC市场安斯泰莱制药盘中异动 早盘股价大涨5.06%报10.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485418890","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485418890?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:46","pubTimestamp":1732200379,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时46分，美国OTC市场安斯泰莱制药股票出现波动，股价快速拉升5.06%。截至发稿，该股报10.58美元/股，成交量1841股，换手率0.00%，振幅6.75%。机构评级方面，在所有14家参与评级的机构中，50%的券商给予买入建议，43%的券商给予持有建议，7%的券商给予卖出建议。美国OTC市场安斯泰莱制药股票所在的制药行业中，整体跌幅为1.21%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122461995be4eed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122461995be4eed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALPMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483882632","title":"美国OTC市场安斯泰莱制药盘中异动 早盘大幅跳水5.05%报10.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483882632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483882632?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:46","pubTimestamp":1731509187,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时46分，美国OTC市场安斯泰莱制药股票出现波动，股价快速跳水5.05%。截至发稿，该股报10.37美元/股，成交量11.4641万股，换手率0.01%，振幅0.00%。机构评级方面，在所有14家参与评级的机构中，50%的券商给予买入建议，43%的券商给予持有建议，7%的券商给予卖出建议。美国OTC市场安斯泰莱制药股票所在的制药行业中，整体涨幅为0.52%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322462795be2402&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322462795be2402&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALPMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2479036310","title":"美国OTC市场安斯泰莱制药盘中异动 股价大跌7.12%报11.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479036310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479036310?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:17","pubTimestamp":1730384221,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时17分，美国OTC市场安斯泰莱制药股票出现异动，股价大幅跳水7.12%。截至发稿，该股报11.42美元/股，成交量277股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入30.36亿美元，净利润2.41亿美元，每股收益0.13美元，毛利22.27亿美元，市盈率49.74倍。美国OTC市场安斯泰莱制药股票所在的制药行业中，整体跌幅为1.32%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122170195bd9d2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122170195bd9d2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALPMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2476272862","title":"安斯泰来(ALPMY.US)CLDN18.2单抗获批一线治疗晚期癌症","url":"https://stock-news.laohu8.com/highlight/detail?id=2476272862","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476272862?lang=zh_cn&edition=full","pubTime":"2024-10-20 08:04","pubTimestamp":1729382645,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，10月20日，安斯泰来宣布美国FDA已批准其靶向Claudin18.2抗体Vyloy与含氟嘧啶和铂类的化疗方案联合，用于局部晚期不可切除或转移性、HER2阴性的胃癌或胃食管结合部腺癌成人患者的一线治疗，这些患者的肿瘤需通过FDA批准的检测确定为CLDN18.2阳性。根据新闻稿，Vyloy是美国FDA批准的首个CLDN18.2靶向疗法。CLDN18.2在包含胃癌在内的消化道癌症中高度表达。因此，CLDN18.2为治疗胃癌、胰腺癌等实体肿瘤的有效靶标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1196355.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4007","ALPMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2472505376","title":"美国OTC市场安斯泰莱制药盘中异动 早盘股价大涨5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472505376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472505376?lang=zh_cn&edition=full","pubTime":"2024-10-01 21:46","pubTimestamp":1727790364,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日21时46分，美国OTC市场安斯泰莱制药股票出现异动，股价快速上涨5.76%。截至发稿，该股报12.11美元/股，成交量105股，换手率0.00%，振幅0.00%。机构评级方面，在所有14家参与评级的机构中，50%的券商给予买入建议，43%的券商给予持有建议，7%的券商给予卖出建议。美国OTC市场安斯泰莱制药股票所在的制药行业中，整体跌幅为0.19%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001214604958a0355&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001214604958a0355&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALPMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.astellas.com/en/index.html","stockEarnings":[{"period":"1week","weight":0.0536},{"period":"1month","weight":0.0272},{"period":"3month","weight":0.0336},{"period":"6month","weight":0.0439},{"period":"1year","weight":-0.1101},{"period":"ytd","weight":0.1762}],"exchange":"PINK LIMITED","name":"Astellas Pharma, Inc.","nameEN":"Astellas Pharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Astellas Pharma, Inc.(ALPMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Astellas Pharma, Inc.(ALPMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Astellas Pharma, Inc.,ALPMY,Astellas Pharma, Inc.股票,Astellas Pharma, Inc.股票老虎,Astellas Pharma, Inc.股票老虎国际,Astellas Pharma, Inc.行情,Astellas Pharma, Inc.股票行情,Astellas Pharma, Inc.股价,Astellas Pharma, Inc.股市,Astellas Pharma, Inc.股票价格,Astellas Pharma, Inc.股票交易,Astellas Pharma, Inc.股票购买,Astellas Pharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Astellas Pharma, Inc.(ALPMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Astellas Pharma, Inc.(ALPMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}